Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 23, 2020

Study Completion Date

March 23, 2020

Conditions
CraniosynostosisMuenke Syndrome
Trial Locations (2)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Unknown

Childrens National Medical Center, Washington D.C.

All Listed Sponsors
lead

National Human Genome Research Institute (NHGRI)

NIH

NCT00106977 - Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis) | Biotech Hunter | Biotech Hunter